Breaking News

Over a month ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Downgrade
Soliton downgraded to Neutral from Buy at Roth Capital » 06:45
06/02/21
06/02
06:45
06/02/21
06:45
SOLY

Soliton

$22.35 /

+0.065 (+0.29%)

Roth Capital analyst…

Roth Capital analyst Scott Henry downgraded Soliton (SOLY) to Neutral from Buy after Allergan Aesthetics, an AbbVie (ABBV) company, announced in May that it will acquire the company for $22.60 per share in cash. He expects the transaction to complete, Henry said.

ShowHide Related Items >><<
SOLY Soliton
$22.35 /

+0.065 (+0.29%)

SOLY Soliton
$22.35 /

+0.065 (+0.29%)

05/13/21
Fly Intel: Top five analyst downgrades
05/13/21 Cantor Fitzgerald
Soliton downgraded to Neutral from Overweight at Cantor Fitzgerald
05/13/21 Cantor Fitzgerald
Soliton downgraded to Neutral from Overweight at Cantor Fitzgerald
05/11/21 Maxim
Soliton downgraded to Hold from Buy at Maxim
SOLY Soliton
$22.35 /

+0.065 (+0.29%)

  • 26
    Jun
SOLY Soliton
$22.35 /

+0.065 (+0.29%)

Downgrade
Fly Intel: Top five analyst downgrades » 09:53
05/13/21
05/13
09:53
05/13/21
09:53
DE

Deere

$373.95 /

+0.2 (+0.05%)

, LITE

Lumentum

$68.19 /

-0.04 (-0.06%)

, ATH

Athene Holding

$61.40 /

+0.87 (+1.44%)

, GRAY

Graybug Vision

$4.01 /

-0.09 (-2.20%)

, SOLY

Soliton

$22.33 /

-0.06 (-0.27%)

Catch up on today's…

Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Deere (DE) downgraded to Market Perform from Outperform at BMO Capital with analyst Joel Tiss saying the analyst views Deere as "less compelling" with the shares up nearly 40% this year and almost 350% over the past five years. 2. Lumentum (LITE) downgraded to Equal Weight from Overweight at Morgan Stanley with analyst Meta Marshall stating that its short term demand drivers are more challenged "in a sector that trades on short term drivers." 3. Athene Holding (ATH) downgraded to Neutral from Buy at UBS with analyst Brian Meredith citing the company's pending merger with Apollo (APO) which is expected to close in Q1 of 2022, noting that his increased price target also reflects the deal for Athene holders to receive a fixed ratio of 1.149 shares of Apollo. 4. Graybug Vision (GRAY) downgraded to Market Perform from Outperform at SVB Leerink and downgraded to Hold from Buy at Needham. 5. Soliton (SOLY) downgraded to Neutral from Overweight at Cantor Fitzgerald with analyst Louise Chen saying she does not see any additional bidders stepping in for Soliton since the company has already run a process for the deal. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

ShowHide Related Items >><<
SOLY Soliton
$22.33 /

-0.06 (-0.27%)

LITE Lumentum
$68.19 /

-0.04 (-0.06%)

GRAY Graybug Vision
$4.01 /

-0.09 (-2.20%)

DE Deere
$373.95 /

+0.2 (+0.05%)

ATH Athene Holding
$61.40 /

+0.87 (+1.44%)

DE Deere
$373.95 /

+0.2 (+0.05%)

05/13/21 Baird
Deere price target raised to $425 from $375 at Baird
05/13/21 BMO Capital
Deere downgraded to Market Perform from Outperform at BMO Capital
05/12/21 Evercore ISI
Deere price target raised to $455 from $389 at Evercore ISI
04/13/21 Deutsche Bank
Deere price target raised to $402 from $360 at Deutsche Bank
LITE Lumentum
$68.19 /

-0.04 (-0.06%)

05/13/21 DA Davidson
Lumentum price target lowered to $95 from $110 at DA Davidson
05/13/21 Needham
Lumentum price target lowered to $87 from $123 at Needham
05/13/21 MKM Partners
Lumentum price target lowered to $86 from $116 at MKM Partners
05/13/21 Craig-Hallum
Lumentum price target lowered to $90 from $120 at Craig-Hallum
ATH Athene Holding
$61.40 /

+0.87 (+1.44%)

05/13/21 UBS
Athene Holding downgraded to Neutral from Buy at UBS
05/13/21 UBS
Athene Holding downgraded to Neutral from Buy at UBS
05/10/21 RBC Capital
Athene Holding price target raised to $60 from $55 at RBC Capital
04/14/21 Oppenheimer
Apollo Global upgraded to Outperform at Oppenheimer
GRAY Graybug Vision
$4.01 /

-0.09 (-2.20%)

05/13/21 Cantor Fitzgerald
Graybug Vision price target lowered to $6 from $14 at Cantor Fitzgerald
05/13/21 Needham
Graybug Vision downgraded to Hold from Buy at Needham
05/12/21 SVB Leerink
Graybug Vision downgraded to Market Perform from Outperform at SVB Leerink
05/12/21 Piper Sandler
Graybug Vision price target lowered to $4 from $10 at Piper Sandler
SOLY Soliton
$22.33 /

-0.06 (-0.27%)

05/13/21 Cantor Fitzgerald
Soliton downgraded to Neutral from Overweight at Cantor Fitzgerald
05/13/21 Cantor Fitzgerald
Soliton downgraded to Neutral from Overweight at Cantor Fitzgerald
05/11/21 Maxim
Soliton downgraded to Hold from Buy at Maxim
05/10/21 Maxim
Soliton downgraded to Hold from Buy at Maxim
SOLY Soliton
$22.33 /

-0.06 (-0.27%)

LITE Lumentum
$68.19 /

-0.04 (-0.06%)

GRAY Graybug Vision
$4.01 /

-0.09 (-2.20%)

DE Deere
$373.95 /

+0.2 (+0.05%)

ATH Athene Holding
$61.40 /

+0.87 (+1.44%)

  • 25
    Sep
  • 26
    Jun
LITE Lumentum
$68.19 /

-0.04 (-0.06%)

DE Deere
$373.95 /

+0.2 (+0.05%)

ATH Athene Holding
$61.40 /

+0.87 (+1.44%)

SOLY Soliton
$22.33 /

-0.06 (-0.27%)

LITE Lumentum
$68.19 /

-0.04 (-0.06%)

DE Deere
$373.95 /

+0.2 (+0.05%)

ATH Athene Holding
$61.40 /

+0.87 (+1.44%)

LITE Lumentum
$68.19 /

-0.04 (-0.06%)

DE Deere
$373.95 /

+0.2 (+0.05%)

Downgrade
Soliton downgraded to Neutral from Overweight at Cantor Fitzgerald » 07:39
05/13/21
05/13
07:39
05/13/21
07:39
SOLY

Soliton

$22.38 /

+0.06 (+0.27%)

, ABBV

AbbVie

$114.93 /

+0.05 (+0.04%)

Cantor Fitzgerald analyst…

Cantor Fitzgerald analyst Louise Chen downgraded Soliton (SOLY) to Neutral from Overweight with a price target of $22.60, down from $25.00, following the recent announcement of Soliton's acquisition by AbbVie's (ABBV) Allergan Aesthetics. Chen does not see any additional bidders stepping in for Soliton since the company has already run a process for the deal, the analyst tells investors in a research note.

ShowHide Related Items >><<
SOLY Soliton
$22.38 /

+0.06 (+0.27%)

ABBV AbbVie
$114.93 /

+0.05 (+0.04%)

SOLY Soliton
$22.38 /

+0.06 (+0.27%)

05/13/21 Cantor Fitzgerald
Soliton downgraded to Neutral from Overweight at Cantor Fitzgerald
05/11/21 Maxim
Soliton downgraded to Hold from Buy at Maxim
05/10/21 Maxim
Soliton downgraded to Hold from Buy at Maxim
03/08/21 Maxim
Soliton's multiple 2021 trials to expand its pipeline, says Maxim
ABBV AbbVie
$114.93 /

+0.05 (+0.04%)

05/03/21 Mizuho
AbbVie price target raised to $128 from $126 at Mizuho
04/30/21 Piper Sandler
AbbVie price target raised to $124 from $120 at Piper Sandler
04/21/21 Citi
Citi sees 'material upside' for AbbVie, Bristol-Myers after Pfizer data
SOLY Soliton
$22.38 /

+0.06 (+0.27%)

ABBV AbbVie
$114.93 /

+0.05 (+0.04%)

  • 26
    Jun
ABBV AbbVie
$114.93 /

+0.05 (+0.04%)

SOLY Soliton
$22.38 /

+0.06 (+0.27%)

ABBV AbbVie
$114.93 /

+0.05 (+0.04%)

ABBV AbbVie
$114.93 /

+0.05 (+0.04%)

Downgrade
Soliton downgraded to Neutral from Overweight at Cantor Fitzgerald » 06:24
05/13/21
05/13
06:24
05/13/21
06:24
SOLY

Soliton

$22.38 /

+0.06 (+0.27%)

Cantor Fitzgerald analyst…

Cantor Fitzgerald analyst Louise Chen downgraded Soliton to Neutral from Overweight.

ShowHide Related Items >><<
SOLY Soliton
$22.38 /

+0.06 (+0.27%)

SOLY Soliton
$22.38 /

+0.06 (+0.27%)

05/11/21 Maxim
Soliton downgraded to Hold from Buy at Maxim
05/10/21 Maxim
Soliton downgraded to Hold from Buy at Maxim
03/08/21 Maxim
Soliton's multiple 2021 trials to expand its pipeline, says Maxim
02/08/21 Maxim
Soliton price target raised to $25 from $22 at Maxim
SOLY Soliton
$22.38 /

+0.06 (+0.27%)

  • 26
    Jun
SOLY Soliton
$22.38 /

+0.06 (+0.27%)

Earnings
Soliton reports Q1 EPS (25c), consensus (25c) » 16:15
05/12/21
05/12
16:15
05/12/21
16:15
SOLY

Soliton

$22.38 /

+0.06 (+0.27%)

Total cash, cash…

Total cash, cash equivalents and restricted cash was $26.3M as of March 31 vs. $31.8M as of December 31, 2020. The company's cash, cash equivalents and restricted cash on hand is expected to be sufficient to fund the company's operations into the third quarter of 2022 and is expected to fully support the initial phase of the commercial launch of Resonic.

ShowHide Related Items >><<
SOLY Soliton
$22.38 /

+0.06 (+0.27%)

SOLY Soliton
$22.38 /

+0.06 (+0.27%)

05/11/21 Maxim
Soliton downgraded to Hold from Buy at Maxim
05/10/21 Maxim
Soliton downgraded to Hold from Buy at Maxim
03/08/21 Maxim
Soliton's multiple 2021 trials to expand its pipeline, says Maxim
02/08/21 Maxim
Soliton price target raised to $25 from $22 at Maxim
SOLY Soliton
$22.38 /

+0.06 (+0.27%)

  • 26
    Jun
SOLY Soliton
$22.38 /

+0.06 (+0.27%)

Downgrade
Soliton downgraded to Hold from Buy at Maxim » 08:22
05/11/21
05/11
08:22
05/11/21
08:22
SOLY

Soliton

$22.40 /

+4.4 (+24.44%)

, ABBV

AbbVie

$116.20 /

+0.44 (+0.38%)

Maxim analyst Anthony…

Maxim analyst Anthony Vendetti downgraded Soliton (SOLY) to Hold from Buy after the company agreed to be acquired by AbbVie's (ABBV) Allergan Aesthetics for $22.60 per share. The analyst believes that the "process in place" prior to the agreement makes any other competing bids unlikely.

ShowHide Related Items >><<
SOLY Soliton
$22.40 /

+4.4 (+24.44%)

ABBV AbbVie
$116.20 /

+0.44 (+0.38%)

SOLY Soliton
$22.40 /

+4.4 (+24.44%)

05/10/21 Maxim
Soliton downgraded to Hold from Buy at Maxim
03/08/21 Maxim
Soliton's multiple 2021 trials to expand its pipeline, says Maxim
02/08/21 Maxim
Soliton price target raised to $25 from $22 at Maxim
02/02/21 Cantor Fitzgerald
Soliton price target raised to $20 from $12 at Cantor Fitzgerald
ABBV AbbVie
$116.20 /

+0.44 (+0.38%)

05/03/21 Mizuho
AbbVie price target raised to $128 from $126 at Mizuho
04/30/21 Piper Sandler
AbbVie price target raised to $124 from $120 at Piper Sandler
04/21/21 Citi
Citi sees 'material upside' for AbbVie, Bristol-Myers after Pfizer data
04/21/21 Citi
Citi opens '90-day positive catalyst' on AbbVie, reiterates Buy rating
SOLY Soliton
$22.40 /

+4.4 (+24.44%)

ABBV AbbVie
$116.20 /

+0.44 (+0.38%)

  • 26
    Jun
ABBV AbbVie
$116.20 /

+0.44 (+0.38%)

SOLY Soliton
$22.40 /

+4.4 (+24.44%)

ABBV AbbVie
$116.20 /

+0.44 (+0.38%)

ABBV AbbVie
$116.20 /

+0.44 (+0.38%)

On The Fly
Fly Intel: Wall Street's top stories for Monday » 16:56
05/10/21
05/10
16:56
05/10/21
16:56
BNTX

BioNTech

$202.59 /

+19.02 (+10.36%)

, PFE

Pfizer

$39.87 /

+0.3 (+0.76%)

, INO

Inovio

$6.70 /

-0.14 (-2.05%)

, NVAX

Novavax

$160.40 /

-15.22 (-8.67%)

, FEYE

FireEye

$19.53 /

+0.22 (+1.14%)

, CRWD

Crowdstrike

$187.33 /

-1.57 (-0.83%)

, PANW

Palo Alto Networks

$341.36 /

-0.985 (-0.29%)

, TENB

Tenable Holdings

$37.37 /

+0.24 (+0.65%)

, GOOG

Alphabet

$2,342.66 /

-55.73 (-2.32%)

, GOOGL

Alphabet Class A

$2,291.86 /

-59.4 (-2.53%)

, ROKU

Roku

$301.23 /

-15.75 (-4.97%)

, FB

Facebook

$305.98 /

-13.02 (-4.08%)

, DUK

Duke Energy

$103.75 /

+2.85 (+2.82%)

, SWBK

Switchback II

$9.99 /

+0.06 (+0.60%)

, CUE

Cue Biopharma

$14.38 /

+3.21 (+28.74%)

, SOLY

Soliton

$22.40 /

+4.4 (+24.44%)

, ABBV

AbbVie

$116.20 /

+0.44 (+0.38%)

, TTD

Trade Desk

$488.00 /

-174.36 (-26.32%)

, INSM

Insmed

$25.99 /

-6.59 (-20.23%)

The major averages had a…

ShowHide Related Items >><<
TTD Trade Desk
$488.00 /

-174.36 (-26.32%)

TENB Tenable Holdings
$37.37 /

+0.24 (+0.65%)

SOLY Soliton
$22.40 /

+4.4 (+24.44%)

ROKU Roku
$301.23 /

-15.75 (-4.97%)

PFE Pfizer
$39.87 /

+0.3 (+0.76%)

PANW Palo Alto Networks
$341.36 /

-0.985 (-0.29%)

NVAX Novavax
$160.40 /

-15.22 (-8.67%)

INSM Insmed
$25.99 /

-6.59 (-20.23%)

INO Inovio
$6.70 /

-0.14 (-2.05%)

GOOGL Alphabet Class A
$2,291.86 /

-59.4 (-2.53%)

GOOG Alphabet
$2,342.66 /

-55.73 (-2.32%)

FEYE FireEye
$19.53 /

+0.22 (+1.14%)

FB Facebook
$305.98 /

-13.02 (-4.08%)

DUK Duke Energy
$103.75 /

+2.85 (+2.82%)

CUE Cue Biopharma
$14.38 /

+3.21 (+28.74%)

CRWD Crowdstrike
$187.33 /

-1.57 (-0.83%)

BNTX BioNTech
$202.59 /

+19.02 (+10.36%)

ABBV AbbVie
$116.20 /

+0.44 (+0.38%)

BNTX BioNTech
$202.59 /

+19.02 (+10.36%)

05/11/21 Bryan Garnier
BioNTech downgraded to Neutral from Buy at Bryan Garnier
02/23/21 B. Riley
B. Riley remains 'aggressive' buyer of Novavax after updated FDA guidance
02/01/21 SVB Leerink
Moderna price target raised to $80 from $69 at SVB Leerink
01/29/21 Piper Sandler
Moderna, Pfizer keep Covid vaccine competitive advantage, says Piper Sandler
PFE Pfizer
$39.87 /

+0.3 (+0.76%)

05/10/21 Morgan Stanley
Pfizer price target raised to $42 from $38 at Morgan Stanley
05/06/21
Fly Intel: Top five analyst downgrades
05/06/21 Mizuho
Pfizer downgraded to Neutral from Buy at Mizuho
05/05/21 JPMorgan
Pfizer price target raised to $40 from $36 at JPMorgan
INO Inovio
$6.70 /

-0.14 (-2.05%)

05/10/21 Piper Sandler
Inovio price target lowered to $6 from $7 at Piper Sandler
05/10/21 Piper Sandler
Inovio Phase 2 data for INO-4800 'lackluster,' says Piper Sandler
04/26/21 B. Riley
B. Riley reiterates Buy on Novavax, Sell on Arcturus amid vaccine developments
04/23/21 Oppenheimer
Oppenheimer still bullish on Inovio after U.S. discontinues trial funding
NVAX Novavax
$160.40 /

-15.22 (-8.67%)

03/26/21 B. Riley
Novavax selloff on 'rumored' production delay overdone, says B. Riley
03/12/21 H.C. Wainwright
Novavax price target raised to $317 from $207 at H.C. Wainwright
FEYE FireEye
$19.53 /

+0.22 (+1.14%)

05/10/21 Goldman Sachs
FireEye could be direct beneficiary of pipeline cyberattack, says Goldman Sachs
02/04/21
Fly Intel: Top five analyst upgrades
02/04/21 BofA
FireEye upgraded to Buy on 'solid execution' at BofA
02/04/21 BofA
FireEye upgraded to Buy from Neutral at BofA
CRWD Crowdstrike
$187.33 /

-1.57 (-0.83%)

04/21/21 Berenberg
Crowdstrike initiated with a Buy at Berenberg
04/15/21
Fly Intel: Top five analyst initiations
04/15/21 Deutsche Bank
Deutsche starts Crowdstrike with Buy rating, $265 price target
PANW Palo Alto Networks
$341.36 /

-0.985 (-0.29%)

04/23/21 KeyBanc
Palo Alto Networks price target raised to $469 from $450 at KeyBanc
04/05/21 Credit Suisse
Palo Alto Networks assumed with an Outperform at Credit Suisse
03/18/21 Mizuho
Palo Alto thesis intact after 'surprising' CFO exit, says Mizuho
TENB Tenable Holdings
$37.37 /

+0.24 (+0.65%)

02/22/21 Barclays
Tenable Holdings initiated with an Overweight at Barclays
02/17/21 Stifel
Tenable Holdings resumed with a Buy at Stifel
02/16/21 Canaccord
Tenable Holdings initiated with a Buy at Canaccord
GOOG Alphabet
$2,342.66 /

-55.73 (-2.32%)

05/10/21
Fly Intel: Top five analyst downgrades
05/10/21 Citi
Citi downgrades Google and Facebook on bullish sell-side expectations
05/10/21 Citi
Facebook downgraded at Citi with Google on concerns over expectations
05/03/21
Fly Intel: Top five analyst upgrades
GOOGL Alphabet Class A
$2,291.86 /

-59.4 (-2.53%)

05/10/21 Citi
ViacomCBS added, Google removed from Citi's Recommended List
ROKU Roku
$301.23 /

-15.75 (-4.97%)

05/07/21 Evercore ISI
Roku price target raised to $430 from $400 at Evercore ISI
05/07/21 KeyBanc
Roku price target lowered to $460 from $518 at KeyBanc
05/07/21 Oppenheimer
Roku price target lowered to $400 from $500 at Oppenheimer
FB Facebook
$305.98 /

-13.02 (-4.08%)

05/10/21 Citi
Facebook downgraded to Neutral from Buy at Citi
04/29/21 KeyBanc
Facebook price target raised to $414 from $360 at KeyBanc
DUK Duke Energy
$103.75 /

+2.85 (+2.82%)

04/14/21 Credit Suisse
Duke Energy price target raised to $104 from $96 at Credit Suisse
04/14/21 Wells Fargo
Duke Energy price target raised to $104 from $97 at Wells Fargo
02/12/21 BofA
Duke Energy downgraded to Neutral from Buy at BofA
02/01/21 Mizuho
Duke Energy price target raised to $96 from $93 at Mizuho
SWBK Switchback II
$9.99 /

+0.06 (+0.60%)

CUE Cue Biopharma
$14.38 /

+3.21 (+28.74%)

11/24/20 Berenberg
Cue Biopharma initiated with a Buy at Berenberg
05/20/20 Oppenheimer
Cue Biopharma price target raised to $32 from $27 at Oppenheimer
05/20/20 BTIG
Cue Biopharma price target raised to $33 from $26 at BTIG
SOLY Soliton
$22.40 /

+4.4 (+24.44%)

05/11/21 Maxim
Soliton downgraded to Hold from Buy at Maxim
05/10/21 Maxim
Soliton downgraded to Hold from Buy at Maxim
03/08/21 Maxim
Soliton's multiple 2021 trials to expand its pipeline, says Maxim
02/08/21 Maxim
Soliton price target raised to $25 from $22 at Maxim
ABBV AbbVie
$116.20 /

+0.44 (+0.38%)

05/03/21 Mizuho
AbbVie price target raised to $128 from $126 at Mizuho
04/30/21 Piper Sandler
AbbVie price target raised to $124 from $120 at Piper Sandler
04/21/21 Citi
Citi sees 'material upside' for AbbVie, Bristol-Myers after Pfizer data
TTD Trade Desk
$488.00 /

-174.36 (-26.32%)

05/11/21 Wells Fargo
Trade Desk price target lowered to $750 from $1,000 at Wells Fargo
05/11/21 KeyBanc
Trade Desk price target lowered to $740 from $851 at KeyBanc
05/11/21 Oppenheimer
Trade Desk price target lowered to $600 from $950 at Oppenheimer
05/11/21 Stifel
Trade Desk price target lowered to $650 from $700 at Stifel
INSM Insmed
$25.99 /

-6.59 (-20.23%)

04/26/21 Credit Suisse
Insmed assumed with an Outperform at Credit Suisse
02/22/21 Credit Suisse
United Therapeutics price target raised to $196 from $169 at Credit Suisse
01/19/21 Credit Suisse
Insmed price target raised to $60 from $50 at Credit Suisse
12/17/20 Berenberg
Insmed initiated with a Buy at Berenberg
TTD Trade Desk
$488.00 /

-174.36 (-26.32%)

TENB Tenable Holdings
$37.37 /

+0.24 (+0.65%)

SOLY Soliton
$22.40 /

+4.4 (+24.44%)

ROKU Roku
$301.23 /

-15.75 (-4.97%)

PFE Pfizer
$39.87 /

+0.3 (+0.76%)

PANW Palo Alto Networks
$341.36 /

-0.985 (-0.29%)

NVAX Novavax
$160.40 /

-15.22 (-8.67%)

INSM Insmed
$25.99 /

-6.59 (-20.23%)

INO Inovio
$6.70 /

-0.14 (-2.05%)

GOOG Alphabet
$2,342.66 /

-55.73 (-2.32%)

FEYE FireEye
$19.53 /

+0.22 (+1.14%)

FB Facebook
$305.98 /

-13.02 (-4.08%)

DUK Duke Energy
$103.75 /

+2.85 (+2.82%)

CUE Cue Biopharma
$14.38 /

+3.21 (+28.74%)

CRWD Crowdstrike
$187.33 /

-1.57 (-0.83%)

BNTX BioNTech
$202.59 /

+19.02 (+10.36%)

ABBV AbbVie
$116.20 /

+0.44 (+0.38%)

  • 11
    May
  • 21
    Jan
  • 31
    Jul
  • 23
    Jul
  • 26
    Jun
  • 26
    Jun
TTD Trade Desk
$488.00 /

-174.36 (-26.32%)

SWBK Switchback II
$9.99 /

+0.06 (+0.60%)

ROKU Roku
$301.23 /

-15.75 (-4.97%)

PFE Pfizer
$39.87 /

+0.3 (+0.76%)

PANW Palo Alto Networks
$341.36 /

-0.985 (-0.29%)

NVAX Novavax
$160.40 /

-15.22 (-8.67%)

GOOG Alphabet
$2,342.66 /

-55.73 (-2.32%)

FEYE FireEye
$19.53 /

+0.22 (+1.14%)

FB Facebook
$305.98 /

-13.02 (-4.08%)

DUK Duke Energy
$103.75 /

+2.85 (+2.82%)

BNTX BioNTech
$202.59 /

+19.02 (+10.36%)

ABBV AbbVie
$116.20 /

+0.44 (+0.38%)

TTD Trade Desk
$488.00 /

-174.36 (-26.32%)

TENB Tenable Holdings
$37.37 /

+0.24 (+0.65%)

ROKU Roku
$301.23 /

-15.75 (-4.97%)

PFE Pfizer
$39.87 /

+0.3 (+0.76%)

PANW Palo Alto Networks
$341.36 /

-0.985 (-0.29%)

NVAX Novavax
$160.40 /

-15.22 (-8.67%)

INO Inovio
$6.70 /

-0.14 (-2.05%)

GOOG Alphabet
$2,342.66 /

-55.73 (-2.32%)

FEYE FireEye
$19.53 /

+0.22 (+1.14%)

FB Facebook
$305.98 /

-13.02 (-4.08%)

CUE Cue Biopharma
$14.38 /

+3.21 (+28.74%)

CRWD Crowdstrike
$187.33 /

-1.57 (-0.83%)

BNTX BioNTech
$202.59 /

+19.02 (+10.36%)

ABBV AbbVie
$116.20 /

+0.44 (+0.38%)

TTD Trade Desk
$488.00 /

-174.36 (-26.32%)

ROKU Roku
$301.23 /

-15.75 (-4.97%)

PFE Pfizer
$39.87 /

+0.3 (+0.76%)

PANW Palo Alto Networks
$341.36 /

-0.985 (-0.29%)

NVAX Novavax
$160.40 /

-15.22 (-8.67%)

INO Inovio
$6.70 /

-0.14 (-2.05%)

GOOGL Alphabet Class A
$2,291.86 /

-59.4 (-2.53%)

GOOG Alphabet
$2,342.66 /

-55.73 (-2.32%)

FEYE FireEye
$19.53 /

+0.22 (+1.14%)

FB Facebook
$305.98 /

-13.02 (-4.08%)

DUK Duke Energy
$103.75 /

+2.85 (+2.82%)

CRWD Crowdstrike
$187.33 /

-1.57 (-0.83%)

BNTX BioNTech
$202.59 /

+19.02 (+10.36%)

ABBV AbbVie
$116.20 /

+0.44 (+0.38%)

Downgrade
Soliton downgraded to Hold from Buy at Maxim » 14:01
05/10/21
05/10
14:01
05/10/21
14:01
SOLY

Soliton

$22.40 /

+4.395 (+24.42%)

Maxim analyst Anthony…

Maxim analyst Anthony Vendetti downgraded Soliton (SOLY) to Hold from Buy after Allergan Aesthetics, an AbbVie (ABBV) company, agreed to acquire Soliton for $22.60 per share in cash.

ShowHide Related Items >><<
SOLY Soliton
$22.40 /

+4.395 (+24.42%)

SOLY Soliton
$22.40 /

+4.395 (+24.42%)

03/08/21 Maxim
Soliton's multiple 2021 trials to expand its pipeline, says Maxim
02/08/21 Maxim
Soliton price target raised to $25 from $22 at Maxim
02/02/21 Cantor Fitzgerald
Soliton price target raised to $20 from $12 at Cantor Fitzgerald
07/15/20 Cantor Fitzgerald
Soliton initiated with an Overweight at Cantor Fitzgerald
SOLY Soliton
$22.40 /

+4.395 (+24.42%)

  • 26
    Jun
SOLY Soliton
$22.40 /

+4.395 (+24.42%)

On The Fly
Fly Intel: Wall Street's top stories at midday » 12:34
05/10/21
05/10
12:34
05/10/21
12:34
NVAX

Novavax

$165.47 /

-10.15 (-5.78%)

, GOOG

Alphabet

$2,357.00 /

-41.39 (-1.73%)

, INSM

Insmed

$25.73 /

-6.85 (-21.03%)

, TTD

Trade Desk

$525.49 /

-136.87 (-20.66%)

, ABBV

AbbVie

$116.38 /

+0.62 (+0.54%)

, SOLY

Soliton

$22.48 /

+4.48 (+24.89%)

, CUE

Cue Biopharma

$14.46 /

+3.29 (+29.45%)

, FEYE

FireEye

$20.26 /

+0.95 (+4.92%)

, ENR

Energizer

$50.92 /

+0.47 (+0.93%)

, FB

Facebook

$308.63 /

-10.37 (-3.25%)

, GOOGL

Alphabet Class A

$2,313.13 /

-38.13 (-1.62%)

, INO

Inovio

$6.91 /

+0.07 (+1.02%)

, PFE

Pfizer

$40.13 /

+0.56 (+1.42%)

, BNTX

BioNTech

$195.30 /

+11.73 (+6.39%)

The major averages are…

ShowHide Related Items >><<
TTD Trade Desk
$525.49 /

-136.87 (-20.66%)

SOLY Soliton
$22.48 /

+4.48 (+24.89%)

PFE Pfizer
$40.13 /

+0.56 (+1.42%)

NVAX Novavax
$165.47 /

-10.15 (-5.78%)

INSM Insmed
$25.73 /

-6.85 (-21.03%)

INO Inovio
$6.91 /

+0.07 (+1.02%)

GOOGL Alphabet Class A
$2,313.13 /

-38.13 (-1.62%)

GOOG Alphabet
$2,357.00 /

-41.39 (-1.73%)

FEYE FireEye
$20.26 /

+0.95 (+4.92%)

FB Facebook
$308.63 /

-10.37 (-3.25%)

ENR Energizer
$50.92 /

+0.47 (+0.93%)

CUE Cue Biopharma
$14.46 /

+3.29 (+29.45%)

BNTX BioNTech
$195.30 /

+11.73 (+6.39%)

ABBV AbbVie
$116.38 /

+0.62 (+0.54%)

NVAX Novavax
$165.47 /

-10.15 (-5.78%)

04/26/21 B. Riley
B. Riley reiterates Buy on Novavax, Sell on Arcturus amid vaccine developments
03/26/21 B. Riley
Novavax selloff on 'rumored' production delay overdone, says B. Riley
03/12/21 H.C. Wainwright
Novavax price target raised to $317 from $207 at H.C. Wainwright
02/23/21 B. Riley
B. Riley remains 'aggressive' buyer of Novavax after updated FDA guidance
GOOG Alphabet
$2,357.00 /

-41.39 (-1.73%)

05/10/21
Fly Intel: Top five analyst downgrades
05/10/21 Citi
Citi downgrades Google and Facebook on bullish sell-side expectations
05/10/21 Citi
Facebook downgraded at Citi with Google on concerns over expectations
05/03/21
Fly Intel: Top five analyst upgrades
INSM Insmed
$25.73 /

-6.85 (-21.03%)

04/26/21 Credit Suisse
Insmed assumed with an Outperform at Credit Suisse
02/22/21 Credit Suisse
United Therapeutics price target raised to $196 from $169 at Credit Suisse
01/19/21 Credit Suisse
Insmed price target raised to $60 from $50 at Credit Suisse
12/17/20 Berenberg
Insmed initiated with a Buy at Berenberg
TTD Trade Desk
$525.49 /

-136.87 (-20.66%)

04/21/21 Vertical Group
Trade Desk upgraded to Positive from Mixed at Vertical Group
04/05/21 Evercore ISI
Trade Desk initiated with an Outperform at Evercore ISI
03/08/21 Oppenheimer
Too soon to tell impact of Chrome policy changes on e-commerce, says Oppenheimer
03/08/21 KeyBanc
Trade Desk upgraded to Overweight from Sector Weight at KeyBanc
ABBV AbbVie
$116.38 /

+0.62 (+0.54%)

05/03/21 Mizuho
AbbVie price target raised to $128 from $126 at Mizuho
04/30/21 Piper Sandler
AbbVie price target raised to $124 from $120 at Piper Sandler
04/21/21 Citi
Citi sees 'material upside' for AbbVie, Bristol-Myers after Pfizer data
04/21/21 Citi
Citi opens '90-day positive catalyst' on AbbVie, reiterates Buy rating
SOLY Soliton
$22.48 /

+4.48 (+24.89%)

05/10/21 Maxim
Soliton downgraded to Hold from Buy at Maxim
03/08/21 Maxim
Soliton's multiple 2021 trials to expand its pipeline, says Maxim
02/08/21 Maxim
Soliton price target raised to $25 from $22 at Maxim
02/02/21 Cantor Fitzgerald
Soliton price target raised to $20 from $12 at Cantor Fitzgerald
CUE Cue Biopharma
$14.46 /

+3.29 (+29.45%)

11/24/20 Berenberg
Cue Biopharma initiated with a Buy at Berenberg
05/20/20 Oppenheimer
Cue Biopharma price target raised to $32 from $27 at Oppenheimer
05/20/20 BTIG
Cue Biopharma price target raised to $33 from $26 at BTIG
FEYE FireEye
$20.26 /

+0.95 (+4.92%)

05/10/21 Goldman Sachs
FireEye could be direct beneficiary of pipeline cyberattack, says Goldman Sachs
02/04/21
Fly Intel: Top five analyst upgrades
02/04/21 BofA
FireEye upgraded to Buy on 'solid execution' at BofA
02/04/21 BofA
FireEye upgraded to Buy from Neutral at BofA
ENR Energizer
$50.92 /

+0.47 (+0.93%)

05/03/21 Deutsche Bank
Energizer price target raised to $56 from $54 at Deutsche Bank
04/16/21 JPMorgan
Energizer price target raised to $52 from $51 at JPMorgan
02/24/21
Fly Intel: Top five analyst downgrades
02/24/21 Goldman Sachs
Energizer downgraded to Neutral from Buy at Goldman Sachs
FB Facebook
$308.63 /

-10.37 (-3.25%)

05/10/21 Citi
Facebook downgraded to Neutral from Buy at Citi
04/29/21 KeyBanc
Facebook price target raised to $414 from $360 at KeyBanc
GOOGL Alphabet Class A
$2,313.13 /

-38.13 (-1.62%)

05/10/21 Citi
Alphabet Class A downgraded to Neutral from Buy at Citi
INO Inovio
$6.91 /

+0.07 (+1.02%)

05/10/21 Piper Sandler
Inovio Phase 2 data for INO-4800 'lackluster,' says Piper Sandler
04/23/21 Oppenheimer
Oppenheimer still bullish on Inovio after U.S. discontinues trial funding
04/23/21 Piper Sandler
Piper 'incrementally cautious' on Inovio, says today's selloff appropriate
PFE Pfizer
$40.13 /

+0.56 (+1.42%)

05/10/21 Morgan Stanley
Pfizer price target raised to $42 from $38 at Morgan Stanley
05/06/21
Fly Intel: Top five analyst downgrades
05/06/21 Mizuho
Pfizer downgraded to Neutral from Buy at Mizuho
05/05/21 JPMorgan
Pfizer price target raised to $40 from $36 at JPMorgan
BNTX BioNTech
$195.30 /

+11.73 (+6.39%)

02/01/21 SVB Leerink
Moderna price target raised to $80 from $69 at SVB Leerink
01/29/21 Piper Sandler
Moderna, Pfizer keep Covid vaccine competitive advantage, says Piper Sandler
01/14/21 Morgan Stanley
80%+ efficacy from J&J vaccine would be 'compelling,' says Morgan Stanley
TTD Trade Desk
$525.49 /

-136.87 (-20.66%)

SOLY Soliton
$22.48 /

+4.48 (+24.89%)

PFE Pfizer
$40.13 /

+0.56 (+1.42%)

NVAX Novavax
$165.47 /

-10.15 (-5.78%)

INSM Insmed
$25.73 /

-6.85 (-21.03%)

INO Inovio
$6.91 /

+0.07 (+1.02%)

GOOG Alphabet
$2,357.00 /

-41.39 (-1.73%)

FEYE FireEye
$20.26 /

+0.95 (+4.92%)

FB Facebook
$308.63 /

-10.37 (-3.25%)

ENR Energizer
$50.92 /

+0.47 (+0.93%)

CUE Cue Biopharma
$14.46 /

+3.29 (+29.45%)

BNTX BioNTech
$195.30 /

+11.73 (+6.39%)

ABBV AbbVie
$116.38 /

+0.62 (+0.54%)

  • 11
    May
  • 21
    Jan
  • 23
    Jul
  • 26
    Jun
TTD Trade Desk
$525.49 /

-136.87 (-20.66%)

PFE Pfizer
$40.13 /

+0.56 (+1.42%)

NVAX Novavax
$165.47 /

-10.15 (-5.78%)

GOOG Alphabet
$2,357.00 /

-41.39 (-1.73%)

FEYE FireEye
$20.26 /

+0.95 (+4.92%)

FB Facebook
$308.63 /

-10.37 (-3.25%)

ENR Energizer
$50.92 /

+0.47 (+0.93%)

BNTX BioNTech
$195.30 /

+11.73 (+6.39%)

ABBV AbbVie
$116.38 /

+0.62 (+0.54%)

TTD Trade Desk
$525.49 /

-136.87 (-20.66%)

PFE Pfizer
$40.13 /

+0.56 (+1.42%)

NVAX Novavax
$165.47 /

-10.15 (-5.78%)

INO Inovio
$6.91 /

+0.07 (+1.02%)

GOOG Alphabet
$2,357.00 /

-41.39 (-1.73%)

FEYE FireEye
$20.26 /

+0.95 (+4.92%)

FB Facebook
$308.63 /

-10.37 (-3.25%)

ENR Energizer
$50.92 /

+0.47 (+0.93%)

CUE Cue Biopharma
$14.46 /

+3.29 (+29.45%)

ABBV AbbVie
$116.38 /

+0.62 (+0.54%)

TTD Trade Desk
$525.49 /

-136.87 (-20.66%)

PFE Pfizer
$40.13 /

+0.56 (+1.42%)

NVAX Novavax
$165.47 /

-10.15 (-5.78%)

INO Inovio
$6.91 /

+0.07 (+1.02%)

GOOGL Alphabet Class A
$2,313.13 /

-38.13 (-1.62%)

GOOG Alphabet
$2,357.00 /

-41.39 (-1.73%)

FEYE FireEye
$20.26 /

+0.95 (+4.92%)

FB Facebook
$308.63 /

-10.37 (-3.25%)

BNTX BioNTech
$195.30 /

+11.73 (+6.39%)

ABBV AbbVie
$116.38 /

+0.62 (+0.54%)

Hot Stocks
Soliton Inc trading resumes  09:00
05/10/21
05/10
09:00
05/10/21
09:00
SOLY

Soliton

$18.00 /

+0.68 (+3.93%)

 
ShowHide Related Items >><<
SOLY Soliton
$18.00 /

+0.68 (+3.93%)

SOLY Soliton
$18.00 /

+0.68 (+3.93%)

03/08/21 Maxim
Soliton's multiple 2021 trials to expand its pipeline, says Maxim
02/08/21 Maxim
Soliton price target raised to $25 from $22 at Maxim
02/02/21 Cantor Fitzgerald
Soliton price target raised to $20 from $12 at Cantor Fitzgerald
07/15/20 Cantor Fitzgerald
Soliton initiated with an Overweight at Cantor Fitzgerald
SOLY Soliton
$18.00 /

+0.68 (+3.93%)

  • 26
    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.